 Plantation, Florida, November 4, 2020 OTC PR WIRE Nutra Pharma Corporation OTC PINK: NPHC, a biotechnology company marketing Nyloxin, Pet Pain-Away and Equine Pain-Away in the over-the-counter OTC pain management market and which is also developing treatments for Multiple Sclerosis MS, Human Immunodeficiency Virus HIV and Pain, provided updates today on their plans and progress involving financing, sales initiatives and the Companys efforts to eliminate toxic debt. 